Legend Biotech Corp (LEGN) Financials
$19.98
$-0.52
(-2.51%)
As on 09-Sep-2026 10:35EDT
Market cap
$4,185 Mln
Revenue (TTM)
$1,271 Mln
P/E Ratio
--
P/B Ratio
3.5
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
1,271.31
|
1,028.90
|
627.24
|
285.14
|
117.01
|
68.83
|
|
|
|
|
|
|
Cost of Revenue
|
552.07
|
408.10
|
234.58
|
144.21
|
65.36
|
313.35
|
|
|
|
|
|
|
Gross Profit
|
719.24
|
620.80
|
392.66
|
140.93
|
51.64
|
68.83
|
|
|
|
|
|
|
Operating Expenses
|
775.40
|
757.30
|
695.90
|
580.41
|
507.26
|
461.11
|
|
|
|
|
|
|
Operating Profit (EBIT)
|
-56.15
|
-136.50
|
-303.24
|
-439.49
|
-455.62
|
-392.29
|
|
|
|
|
|
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
-56.27
|
-282.60
|
-158.13
|
-520.12
|
-445.72
|
-407.20
|
|
|
|
|
|
|
Provision for Tax
|
35.33
|
14.20
|
18.89
|
-1.86
|
0.63
|
-3.61
|
|
|
|
|
|
|
Profit after Tax (Net Income)
|
-91.60
|
-296.80
|
-177.03
|
-518.25
|
-446.35
|
-403.58
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
-446.35
|
-386.21
|
|
|
|
|
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,229.64
|
1,002.10
|
1,040.55
|
1,251.37
|
744.31
|
765.94
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
117.70
|
95.20
|
351.96
|
380.82
|
288.86
|
124.32
|
|
|
|
|
|
|
Current Liabilities
|
403.61
|
636.40
|
277.65
|
216.42
|
297.79
|
229.20
|
|
|
|
|
|
|
Total Liabilities
|
2,154.57
|
1,733.70
|
1,670.15
|
1,848.61
|
1,330.96
|
1,119.47
|
|
|
|
|
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
523.52
|
486.60
|
386.24
|
350.81
|
231.84
|
169.62
|
|
|
|
|
|
|
Current Assets
|
1,227.44
|
1,247.10
|
1,283.92
|
1,497.80
|
1,099.12
|
949.85
|
|
|
|
|
|
|
Total Assets
|
2,154.60
|
1,733.70
|
1,670.15
|
1,848.61
|
1,330.96
|
1,119.47
|
|
|
|
|
|
|
Total Debt*
|
278.21
|
413.70
|
350.60
|
328.67
|
284.53
|
122.97
|
|
|
|
|
|
|
Net Current Assets
|
823.80
|
610.70
|
1,006.27
|
1,281.38
|
801.33
|
668.49
|
|
|
|
|
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-100.47
|
-144.03
|
-393.28
|
-201.28
|
-198.47
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
711.48
|
-850.54
|
92.79
|
-77.09
|
-194.98
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-0.30
|
5.70
|
791.49
|
377.98
|
626.66
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-0.50
|
-1.61
|
-0.97
|
-2.85
|
-2.81
|
-2.75
|
|
|
|
|
|
|
Cash EPS ($)
|
--
|
-1.45
|
-0.84
|
-2.74
|
-2.69
|
-2.66
|
|
|
|
|
|
|
Adjusted Book Value ($)
|
--
|
5.42
|
5.69
|
6.88
|
4.68
|
5.22
|
|
|
|
|
|
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share ($)
|
--
|
-0.54
|
-0.79
|
-2.16
|
-1.27
|
-1.35
|
|
|
|
|
|
|
Free Cash Flow per Share ($)
|
--
|
-0.91
|
-0.86
|
-2.29
|
-1.41
|
-1.66
|
|
|
|
|
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-21.15
|
-11.92
|
-39.73
|
-46.55
|
-54.16
|
|
|
|
|
|
|
ROE (%)
|
-8.21
|
-29.06
|
-15.45
|
-51.94
|
-59.11
|
-59.19
|
|
|
|
|
|
|
ROA (%)
|
-4.46
|
-17.44
|
-10.06
|
-32.60
|
-36.43
|
-43.83
|
|
|
|
|
|
|
EBIT Margin (%)
|
-3.39
|
-25.39
|
-21.76
|
-174.76
|
-371.72
|
-590.32
|
|
|
|
|
|
|
Net Margin (%)
|
-7.21
|
-28.85
|
-28.22
|
-181.75
|
-381.48
|
-586.38
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
59.54
|
0.64
|
1.20
|
1.44
|
0.70
|
-0.08
|
|
|
|
|
|
|
EBIT Growth (%)
|
84.79
|
-91.33
|
72.60
|
-14.58
|
-7.05
|
-31.88
|
|
|
|
|
|
|
Net Profit Growth (%)
|
71.84
|
-67.66
|
65.84
|
-16.11
|
-10.60
|
-51.51
|
|
|
|
|
|
|
EPS Growth (%)
|
71.54
|
-0.66
|
0.66
|
-0.02
|
-0.02
|
-0.37
|
|
|
|
|
|
|
Book Value Growth (%)
|
12.82
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
-13.53
|
-33.61
|
-21.12
|
-17.79
|
-16.93
|
|
|
|
|
|
|
Price / Book Value
|
3.46
|
4.01
|
5.72
|
8.75
|
10.67
|
8.92
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
310.52
|
-14.99
|
-45.76
|
-20.85
|
-17.28
|
-15.48
|
|
|
|
|
|
|
Close Price ($)
|
28.88
|
21.74
|
32.54
|
60.17
|
49.92
|
46.61
|
|
|
|
|
|
|
High Price ($)
|
45.30
|
45.30
|
70.13
|
77.32
|
57.67
|
58.00
|
|
|
|
|
|
|
Low Price ($)
|
16.24
|
21.19
|
32.08
|
42.91
|
30.76
|
23.41
|
|
|
|
|
|
|
Market Cap ($ Cr)
|
4,185.39
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.41
|
0.34
|
0.26
|
0.38
|
0.16
|
|
|
|
|
|
|
Short term debt to equity ratio
|
0.14
|
0.33
|
0.00
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
Current Ratio
|
3.04
|
1.96
|
4.62
|
6.92
|
3.69
|
4.14
|
|
|
|
|
|
|
Quick Ratio
|
2.94
|
1.91
|
4.54
|
6.83
|
3.66
|
4.14
|
|
|
|
|
|
|
Interest Coverage
|
-2.34
|
-12.21
|
-6.32
|
-22.87
|
-40.29
|
-451.44
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
15.58
|
24.33
|
19.91
|
55.08
|
38.05
|
85.07
|
|
|
|
|
|
|
Asset Turnover
|
0.62
|
0.60
|
0.36
|
0.18
|
0.10
|
0.07
|
|
|
|
|
|
|
Receivable days
|
--
|
66.59
|
82.09
|
129.10
|
160.86
|
374.57
|
|
|
|
|
|
|
Inventory Days
|
--
|
25.02
|
33.74
|
37.72
|
33.82
|
2.07
|
|
|
|
|
|
|
Payable days
|
--
|
52.98
|
44.65
|
65.66
|
108.23
|
6.97
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
38.63
|
71.18
|
101.16
|
86.45
|
369.67
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
